Follow The Filings

MRK Merck

Health Care, filed as MERCK & CO INC (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 3

  • 3 Owners
  • #52
  • Max 0.8%
  • Master 0.10%
  • $4.1M
  • 1 add 2 reduce 1 exit

In 2026 Q3 Kentucky Trust added to Merck, Murphy Pohlad and David Katz trimmed, and Richard Pzena sold out.

Who owns this now

Largest portfolio weights among holders, up to 0.8% (Murphy Pohlad, Murphy Pohlad Asset Management). Not free-float ownership.

  1. Murphy Pohlad Reduce 0.83%
  2. Kentucky Trust Co. Add 0.74%
  3. David Katz Reduce 0.02%

Who owns MRK

Sorted by value, long equity only, as of 2026 Q3.

History
Murphy Pohlad, Murphy Pohlad Asset Management 0.83% Reduce −3.0% 16,507 $2.4M History
Kentucky Trust Co., Kentucky Trust 0.74%, was 0.62% Add +1.0% 10,180 $1.5M History
David Katz, Matrix Asset Advisors 0.02% Reduce −3.0% 1,621 $236K History
Richard Pzena, Pzena Investment Management exited 2026 Q3 Last 2026 Q2 <0.01% Exit 0.00% 2,511 $323K History

3 current, 1 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by MRK's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MRK insider trades
  • None no insider bought on the open market
  • $31.3M sold by 6 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Chirfi Guindo EVP, Access, Policy & Comms
    Sale
    $1.4M 10,000 shares at $135.00 22% of stake
    Traded Aug 13 Filed Aug 13
    ↗
  2. Jennifer Zachary EVP, General Counsel
    Sale
    $10.7M 80,315 shares at $133.46 64% of stake
    Traded Aug 12 Filed Aug 13
    ↗
  3. Richard R. DeLuca EVP&Pres, Merck Animal Heallth
    Sale
    $5.9M 45,320 shares at $131.12 29% of stake
    Traded Aug 10–12 Filed Aug 12
    ↗
  4. Richard R. DeLuca EVP&Pres, Merck Animal Heallth
    Sale
    $789K 6,050 shares at $130.38 3.7% of stake
    Traded Aug 6 Filed Aug 10
    ↗
  5. David R. Maraldo EVP & Pres. MMD
    Sale
    $2.4M 18,706 shares at $128.72 51% of stake
    Traded Aug 5 Filed Aug 7
    ↗
  6. David Michael Williams EVP,Chief Info&Digital Officer
    Sale
    $6.8M 52,847 shares at $128.77 63% of stake
    Traded Aug 5 Filed Aug 7
    ↗
  7. Chirfi Guindo EVP, Access, Policy & Comms
    Sale
    $2M 15,000 shares at $131.00 24% of stake
    Traded Aug 6 Filed Aug 7
    ↗
  8. Cristal N Downing Chief Comm. & Public Afrs Ofcr
    Sale
    $616K 7,085 shares at $87.00 100% of stake
    Traded Nov 10, 2025 Filed Nov 12, 2025
    ↗
  9. David Michael Williams EVP,Chief Info&Digital Officer
    Sale
    $720K 8,614 shares at $83.59 26% of stake
    Traded Nov 3, 2025 Filed Nov 4, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 23 option exercises, 15 share withholdings for taxes, and 11 stock grants.

Congress

21 members of Congress traded MRK in the last three years: 29 buys and 28 sales. 29 members listed it in 2025 annual reports.

All Congress trades
  1. Maria Elvira Salazar R-FL-27 Partial sale $1K–$15K Sep 24 filed Oct 7
  2. Maria Elvira Salazar R-FL-27 Buy $15K–$50K Aug 19 filed Sep 9
  3. Maria Elvira Salazar R-FL-27 Buy $15K–$50K Aug 19 filed Sep 9
  4. Alan Armstrong R-OK Sell $15K–$50K Mar 27 filed Jul 21
  5. Josh Gottheimer D-NJ-5Joint Buy $1K–$15K Feb 4 filed Mar 16
  6. Julie Johnson D-TX-32Joint Sell $1K–$15K Dec 18, 2025 filed Jan 15

SEC filings

Recent issuer filings from EDGAR, 8 shown.

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
8-K 5.02 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 8.01,9.01 Filing Doc
424B5 Filing Doc
424B5 Filing Doc

Source: SEC EDGAR submissions, updated 1 day ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $60.12B $64.17B $65.01B
Gross profit * $43.99B $48.98B $48.63B
Gross margin * 73.2% 76.3% 74.8%
Net income $0.365B $17.12B $18.25B
Net margin * 0.6% 26.7% 28.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $32.17B $38.78B $43.52B
Total non-current assets * $74.51B $78.32B $93.35B
Total assets $106.68B $117.11B $136.87B
Total current liabilities $25.69B $28.42B $28.33B
Total equity $37.58B $46.31B $52.61B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations — $21.47B $16.47B
Cash from investing — -$7.73B -$13.74B
Cash from financing — -$7.03B -$1.92B
Net change in cash -$5.86B $6.41B $1.37B

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.